| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
C Eric Winzer is Director at AURX. C Eric Winzer's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $220K at current prices.
Net of sales, the AURX filings show accumulation of 25,000 shares.
C Eric Winzer has 10 Form 4 filings on record from January 2015 to June 2026, all as Director at Nuo Therapeutics (AURX), 2015–2026.
The 15 reported transactions were 8 option or other derivative awards, 3 option exercises, 3 tax withholdings and 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $25K and no sales.
The only open-market purchase was 25,000 shares of AURX at an average $1.00 on May 5, 2016, about $25K.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 5, 2016 | AURX Nuo Therapeutics, Inc. | Director | Buy | 25,000 | $1.00 | $25,000.00 | New |